Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs141748019 | chr13:114153193 | CAA/C | 4.5E-12 | 177 | 24.17 | 29.57 | 3.32 | KM Plot |
PCPG | rs141764817 | chr21:38466986 | A/AT | 9.32E-9 | 176 | 25.17 | 25.87 | 3.83 | KM Plot |
PCPG | rs141769382 | chr2:108529435 | C/G | 1.11E-16 | 170 | 25.43 | 25.67 | 3.17 | KM Plot |
PCPG | rs141809032 | chr2:98372619 | A/ATGAT | 8.01E-9 | 178 | 25.17 | 25.53 | 6.15 | KM Plot |
PCPG | rs141871716 | chr17:1450378 | GCA/G | 1.49E-5 | 175 | 24.53 | 25.87 | 25.17 | KM Plot |
PCPG | rs142059189 | chr17:1422356 | TC/T | 1.37E-5 | 176 | 24.7 | 25.87 | 13.02 | KM Plot |
PCPG | rs142119790 | chr8:126183951 | T/TATA | 3.12E-5 | 177 | 25.53 | 28.3 | 4.17 | KM Plot |
PCPG | rs142269893 | chr7:105162629 | T/G | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs142312641 | chr2:121539197 | GC/G | 0.000252 | 174 | 25.53 | 24.23 | 59.77 | KM Plot |
PCPG | rs142324044 | chr1:36433070 | C/T | 0.000208 | 175 | 25.53 | 24.7 | 10.3 | KM Plot |
PCPG | rs142358444 | chr2:24318674 | T/C | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs142370407 | chr1:36430202 | C/G | 0.000208 | 175 | 25.53 | 24.7 | 10.3 | KM Plot |
PCPG | rs142382996 | chr16:89904834 | G/C | 0.000182 | 173 | 25.87 | 23.37 | 36.37 | KM Plot |
PCPG | rs142388692 | chr2:136545182 | CTAAA/C | 2.99E-5 | 175 | 25.87 | 23.77 | 9.72 | KM Plot |
PCPG | rs142461099 | chr5:50602739 | G/T | 7.17E-5 | 176 | 25.28 | 24.62 | 31.35 | KM Plot |